vs
Side-by-side financial comparison of IDEAYA Biosciences, Inc. (IDYA) and SILVERCORP METALS INC (SVM). Click either name above to swap in a different company.
SILVERCORP METALS INC is the larger business by last-quarter revenue ($223.8M vs $207.8M, roughly 1.1× IDEAYA Biosciences, Inc.). IDEAYA Biosciences, Inc. runs the higher net margin — 57.4% vs -1.3%, a 58.7% gap on every dollar of revenue.
IDEAYA Biosciences, Inc. is a clinical-stage biotechnology company focused on oncology, developing targeted therapies and synthetic lethality treatments for patients with genetically defined cancers. It advances a pipeline of candidates across multiple tumor types, partnering with industry stakeholders to accelerate global access to innovative cancer care solutions.
Silvercorp Metals Inc. (Silvercorp) is a Canadian-based, China-focused precious metals company engaged in the acquisition, exploration, and development of silver-containing properties.
IDYA vs SVM — Head-to-Head
Income Statement — Q3 FY2025 vs Q3 FY2026
| Metric | | |
|---|---|---|
| Revenue | $207.8M | $223.8M |
| Net Profit | $119.2M | $-2.9M |
| Gross Margin | — | — |
| Operating Margin | 52.2% | — |
| Net Margin | 57.4% | -1.3% |
| Revenue YoY | — | — |
| Net Profit YoY | 330.1% | — |
| EPS (diluted) | $1.33 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $223.8M | ||
| Q3 25 | $207.8M | — | ||
| Q2 25 | — | $72.2M | ||
| Q4 24 | — | $172.5M | ||
| Q3 24 | $0 | $114.0M | ||
| Q2 24 | $0 | $60.0M | ||
| Q1 24 | $0 | — | ||
| Q4 23 | — | $174.0M |
| Q4 25 | — | $-2.9M | ||
| Q3 25 | $119.2M | — | ||
| Q2 25 | — | $28.1M | ||
| Q4 24 | — | $42.1M | ||
| Q3 24 | $-51.8M | $28.0M | ||
| Q2 24 | $-52.8M | $13.2M | ||
| Q1 24 | $-39.6M | — | ||
| Q4 23 | — | $18.8M |
| Q4 25 | — | — | ||
| Q3 25 | 52.2% | — | ||
| Q2 25 | — | — | ||
| Q4 24 | — | 30.5% | ||
| Q3 24 | — | 30.7% | ||
| Q2 24 | — | 30.0% | ||
| Q1 24 | — | — | ||
| Q4 23 | — | 16.8% |
| Q4 25 | — | -1.3% | ||
| Q3 25 | 57.4% | — | ||
| Q2 25 | — | 39.0% | ||
| Q4 24 | — | 24.4% | ||
| Q3 24 | — | 24.5% | ||
| Q2 24 | — | 22.0% | ||
| Q1 24 | — | — | ||
| Q4 23 | — | 10.8% |
| Q4 25 | — | — | ||
| Q3 25 | $1.33 | — | ||
| Q2 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $-0.60 | — | ||
| Q2 24 | $-0.68 | — | ||
| Q1 24 | $-0.53 | — | ||
| Q4 23 | — | $0.11 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $786.9M | — |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $1.1B | — |
| Total Assets | $1.2B | — |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | — | ||
| Q3 25 | $786.9M | — | ||
| Q2 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $920.0M | — | ||
| Q2 24 | $701.7M | — | ||
| Q1 24 | $698.8M | — | ||
| Q4 23 | — | — |
| Q4 25 | — | — | ||
| Q3 25 | $1.1B | — | ||
| Q2 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $1.2B | — | ||
| Q2 24 | $931.7M | — | ||
| Q1 24 | $935.3M | — | ||
| Q4 23 | — | — |
| Q4 25 | — | — | ||
| Q3 25 | $1.2B | — | ||
| Q2 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $1.2B | — | ||
| Q2 24 | $973.7M | — | ||
| Q1 24 | $961.5M | — | ||
| Q4 23 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $142.2M | $107.9M |
| Free Cash FlowOCF − Capex | $142.2M | — |
| FCF MarginFCF / Revenue | 68.4% | — |
| Capex IntensityCapex / Revenue | 0.0% | — |
| Cash ConversionOCF / Net Profit | 1.19× | — |
| TTM Free Cash FlowTrailing 4 quarters | $13.5M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $107.9M | ||
| Q3 25 | $142.2M | — | ||
| Q2 25 | — | $40.0M | ||
| Q4 24 | — | $81.3M | ||
| Q3 24 | $-49.2M | $57.7M | ||
| Q2 24 | $-32.9M | $28.9M | ||
| Q1 24 | $-43.8M | — | ||
| Q4 23 | — | $79.9M |
| Q4 25 | — | — | ||
| Q3 25 | $142.2M | — | ||
| Q2 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $-49.7M | $33.8M | ||
| Q2 24 | $-33.9M | $17.0M | ||
| Q1 24 | $-45.1M | — | ||
| Q4 23 | — | $45.7M |
| Q4 25 | — | — | ||
| Q3 25 | 68.4% | — | ||
| Q2 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 29.6% | ||
| Q2 24 | — | 28.3% | ||
| Q1 24 | — | — | ||
| Q4 23 | — | 26.2% |
| Q4 25 | — | — | ||
| Q3 25 | 0.0% | — | ||
| Q2 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 21.0% | ||
| Q2 24 | — | 19.8% | ||
| Q1 24 | — | — | ||
| Q4 23 | — | 19.7% |
| Q4 25 | — | — | ||
| Q3 25 | 1.19× | — | ||
| Q2 25 | — | 1.42× | ||
| Q4 24 | — | 1.93× | ||
| Q3 24 | — | 2.06× | ||
| Q2 24 | — | 2.19× | ||
| Q1 24 | — | — | ||
| Q4 23 | — | 4.25× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
